Notch1 modulates timing of G1-S progression by inducing SKP2 transcription and p27Kip1 degradation

Cyclin-dependent kinase inhibitors (CKIs) and Notch receptor activation have been shown to influence adult stem cells and progenitors by altering stem cell self-renewal and proliferation. Yet, no interaction between these molecular pathways has been defined. Here we show that ligand-independent and...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of experimental medicine Vol. 202; no. 1; pp. 157 - 168
Main Authors: Sarmento, Leonor M., Huang, Hui, Limon, Ana, Gordon, William, Fernandes, Jacquenilson, Tavares, Maria J., Miele, Lucio, Cardoso, Angelo A., Classon, Marie, Carlesso, Nadia
Format: Journal Article
Language:English
Published: The Rockefeller University Press 04-07-2005
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cyclin-dependent kinase inhibitors (CKIs) and Notch receptor activation have been shown to influence adult stem cells and progenitors by altering stem cell self-renewal and proliferation. Yet, no interaction between these molecular pathways has been defined. Here we show that ligand-independent and ligand-dependent activation of Notch1 induces transcription of the S phase kinase–associated protein 2 (SKP2), the F-box subunit of the ubiquitin-ligase complex SCFSKP2 that targets proteins for degradation. Up-regulation of SKP2 by Notch signaling enhances proteasome-mediated degradation of the CKIs, p27Kip1 and p21Cip1, and causes premature entry into S phase. Silencing of SKP2 by RNA interference in G1 stabilizes p27Kip1 and p21Cip1 and abolishes Notch effect on G1-S progression. Thus, SKP2 serves to link Notch1 activation with the cell cycle machinery. This novel pathway involving Notch/SKP2/CKIs connects a cell surface receptor with proximate mediators of cell cycle activity, and suggests a mechanism by which a known physiologic mediator of cell fate determination interfaces with cell cycle control.
Bibliography:Abbreviations used: ATRA, all-trans-retinoic acid; CDK, cyclin-dependent kinase; CKI, cyclin-dependent kinase inhibitor; ΔE, intracellular with transmembrane domain of Notch; Dll, Delta-like; EMSA, electrophoretic mobility shift assay; GSI, γ-secretase inhibitor; ICN, intracellular domain of Notch; IP, immunoprecipitation; J1, Jagged1; J2, Jagged2; N1, Notch1; N1AS, N1 antisense; Notchic, Notch intracellular domain; SCF, SKP1/CUL1/F-box; siRNA, small interfering RNA; SKP2, S phase kinase–associated protein 2.
CORRESPONDENCE Nadia Carlesso: carlesso.nadia@mgh.harvard.edu
ISSN:0022-1007
1540-9538
DOI:10.1084/jem.20050559